InMed Pharmaceuticals Inc [INM] stock prices are up 28.24% to $3.36 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INM shares have gain 22.81% over the last week, with a monthly amount glided 27.27%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of InMed Pharmaceuticals Inc [INM] has been fluctuating between $1.72 and $15.70 over the past year. InMed Pharmaceuticals Inc [NASDAQ: INM] shares were valued at $3.36 at the most recent close of the market.
Analyzing the INM fundamentals
The InMed Pharmaceuticals Inc [NASDAQ:INM] reported sales of 4.92M for trailing twelve months, representing a surge of 7.59%. Gross Profit Margin for this corporation currently stands at -2.67% with Operating Profit Margin at -1.77%, Pretax Profit Margin comes in at -1.98%, and Net Profit Margin reading is -2.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.69, Equity is -1.93 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.65 points at the first support level, and at 1.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.03, and for the 2nd resistance point, it is at 4.71.
Ratios To Look Out For
It’s worth pointing out that InMed Pharmaceuticals Inc [NASDAQ:INM]’s Current Ratio is 3.49. Also, the Quick Ratio is 3.04, while the Cash Ratio stands at 2.54. Considering the valuation of this stock, the price to sales ratio is 0.83, the price to book ratio is 0.58.
Transactions by insiders
Recent insider trading involved MANCINI ALEXANDRA DIANE JANET, Consultant, that happened on Jul 31 ’24 when 240.0 shares were sold.
